214 related articles for article (PubMed ID: 35529336)
1. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol.
Buonsenso D; Munblit D; Pazukhina E; Ricchiuto A; Sinatti D; Zona M; De Matteis A; D'Ilario F; Gentili C; Lanni R; Rongai T; Del Balzo P; Fonte MT; Valente M; Zampino G; De Rose C; Sigfrid L; Valentini P;
Front Pediatr; 2022; 10():834875. PubMed ID: 35529336
[TBL] [Abstract][Full Text] [Related]
2. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy.
Buonsenso D; Pazukhina E; Gentili C; Vetrugno L; Morello R; Zona M; De Matteis A; D'Ilario F; Lanni R; Rongai T; Del Balzo P; Fonte MT; Valente M; De Rose C; Munblit D; Sigfrid L; Valentini P
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431250
[TBL] [Abstract][Full Text] [Related]
4. Extended coagulation profile of children with Long Covid: a prospective study.
Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program.
Rao S; Lee GM; Razzaghi H; Lorman V; Mejias A; Pajor NM; Thacker D; Webb R; Dickinson K; Bailey LC; Jhaveri R; Christakis DA; Bennett TD; Chen Y; Forrest CB
medRxiv; 2022 May; ():. PubMed ID: 35665016
[TBL] [Abstract][Full Text] [Related]
6. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study.
Osmanov IM; Spiridonova E; Bobkova P; Gamirova A; Shikhaleva A; Andreeva M; Blyuss O; El-Taravi Y; DunnGalvin A; Comberiati P; Peroni DG; Apfelbacher C; Genuneit J; Mazankova L; Miroshina A; Chistyakova E; Samitova E; Borzakova S; Bondarenko E; Korsunskiy AA; Konova I; Hanson SW; Carson G; Sigfrid L; Scott JT; Greenhawt M; Whittaker EA; Garralda E; Swann OV; Buonsenso D; Nicholls DE; Simpson F; Jones C; Semple MG; Warner JO; Vos T; Olliaro P; Munblit D;
Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34210789
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Seroconversion in Children and Adults With Mild COVID-19.
Toh ZQ; Anderson J; Mazarakis N; Neeland M; Higgins RA; Rautenbacher K; Dohle K; Nguyen J; Overmars I; Donato C; Sarkar S; Clifford V; Daley A; Nicholson S; Mordant FL; Subbarao K; Burgner DP; Curtis N; Bines JE; McNab S; Steer AC; Mulholland K; Tosif S; Crawford NW; Pellicci DG; Do LAH; Licciardi PV
JAMA Netw Open; 2022 Mar; 5(3):e221313. PubMed ID: 35262717
[TBL] [Abstract][Full Text] [Related]
10. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study.
Scherlinger M; Pijnenburg L; Chatelus E; Arnaud L; Gottenberg JE; Sibilia J; Felten R
Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062706
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
Morello R; Mariani F; Mastrantoni L; De Rose C; Zampino G; Munblit D; Sigfrid L; Valentini P; Buonsenso D
EClinicalMedicine; 2023 May; 59():101961. PubMed ID: 37073325
[TBL] [Abstract][Full Text] [Related]
12. Long term sequelae after SARS-CoV-2 infection in children: a household study.
Sluiter-Post JGC; Fourie E; Wildenbeest JG; van Lelyveld SFL; Bruijning-Verhagen PCJL; van Houten MA
Virol J; 2023 Jun; 20(1):137. PubMed ID: 37380990
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.
Boekel L; Atiqi S; Leeuw M; Hooijberg F; Besten YR; Wartena R; Steenhuis M; Vogelzang E; Webers C; Boonen A; Gerritsen M; Lems WF; Tas SW; van Vollenhoven RF; Voskuyl AE; van der Horst-Bruinsma I; Nurmohamed M; Rispens T; Wolbink G
Lancet Rheumatol; 2023 Jul; 5(7):e375-e385. PubMed ID: 37398978
[TBL] [Abstract][Full Text] [Related]
14. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-like symptoms and their relation to the SARS-CoV-2 epidemic in children and adults of an Italian birth cohort.
Popovic M; Moccia C; Isaevska E; Moirano G; Pizzi C; Zugna D; Rusconi F; Merletti F; Maule M; Richiardi L
Epidemiol Prev; 2021; 45(6):486-495. PubMed ID: 34545726
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
17. Post-COVID-19 Condition in Children 6 and 12 Months After Infection.
Dun-Dery F; Xie J; Winston K; Burstein B; Gravel J; Emsley J; Sabhaney V; Zemek R; Berthelot S; Beer D; Kam A; Freire G; Mater A; Porter R; Poonai N; Moffatt A; Dixon A; Salvadori MI; Freedman SB;
JAMA Netw Open; 2023 Dec; 6(12):e2349613. PubMed ID: 38153737
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
Brotons P; Launes C; Buetas E; Fumado V; Henares D; de Sevilla MF; Redin A; Fuente-Soro L; Cuadras D; Mele M; Jou C; Millat P; Jordan I; Garcia-Garcia JJ; Bassat Q; Muñoz-Almagro C;
Clin Infect Dis; 2021 Jun; 72(12):e970-e977. PubMed ID: 33180914
[TBL] [Abstract][Full Text] [Related]
19. Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.
Gebhard CE; Sütsch C; Gebert P; Gysi B; Bengs S; Todorov A; Deforth M; Buehler PK; Meisel A; Schuepbach RA; Zinkernagel AS; Brugger SD; Acevedo C; Patriki D; Wiggli B; Beer JH; Friedl A; Twerenbold R; Kuster GM; Pargger H; Tschudin-Sutter S; Schefold JC; Spinetti T; Henze C; Pasqualini M; Sager DF; Mayrhofer L; Grieder M; Tontsch J; Franzeck FC; Wendel Garcia PD; Hofmaenner DA; Scheier T; Bartussek J; Haider A; Grämer M; Mikail N; Rossi A; Zellweger N; Opić P; Portmann A; von Känel R; Pazhenkottil AP; Messerli M; Buechel RR; Kaufmann PA; Treyer V; Siegemund M; Held U; Regitz-Zagrosek V; Gebhard C
Euro Surveill; 2024 Jan; 29(2):. PubMed ID: 38214079
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.
Munblit D; Bobkova P; Spiridonova E; Shikhaleva A; Gamirova A; Blyuss O; Nekliudov N; Bugaeva P; Andreeva M; DunnGalvin A; Comberiati P; Apfelbacher C; Genuneit J; Avdeev S; Kapustina V; Guekht A; Fomin V; Svistunov AA; Timashev P; Subbot VS; Royuk VV; Drake TM; Hanson SW; Merson L; Carson G; Horby P; Sigfrid L; Scott JT; Semple MG; Warner JO; Vos T; Olliaro P; Glybochko P; Butnaru D;
Clin Exp Allergy; 2021 Sep; 51(9):1107-1120. PubMed ID: 34351016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
